SI1148873T1 - Highly purified ethyl epa and other epa derivatives for neurological disorders - Google Patents
Highly purified ethyl epa and other epa derivatives for neurological disordersInfo
- Publication number
- SI1148873T1 SI1148873T1 SI200030748T SI200030748T SI1148873T1 SI 1148873 T1 SI1148873 T1 SI 1148873T1 SI 200030748 T SI200030748 T SI 200030748T SI 200030748 T SI200030748 T SI 200030748T SI 1148873 T1 SI1148873 T1 SI 1148873T1
- Authority
- SI
- Slovenia
- Prior art keywords
- epa
- highly purified
- neurological disorders
- derivatives
- purified ethyl
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9901809.5A GB9901809D0 (en) | 1999-01-27 | 1999-01-27 | Highly purified ethgyl epa and other epa derivatives for psychiatric and neurological disorderes |
PCT/GB2000/000164 WO2000044361A2 (en) | 1999-01-27 | 2000-01-21 | Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders |
EP00900733A EP1148873B1 (en) | 1999-01-27 | 2000-01-21 | Highly purified ethyl epa and other epa derivatives for neurological disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1148873T1 true SI1148873T1 (en) | 2005-12-31 |
Family
ID=32109055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200030748T SI1148873T1 (en) | 1999-01-27 | 2000-01-21 | Highly purified ethyl epa and other epa derivatives for neurological disorders |
Country Status (1)
Country | Link |
---|---|
SI (1) | SI1148873T1 (en) |
-
2000
- 2000-01-21 SI SI200030748T patent/SI1148873T1/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HUP0105215A3 (en) | Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders | |
IL153425A0 (en) | Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders | |
HK1052647A1 (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of cns disorders | |
IL133800A0 (en) | Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders | |
AUPM864894A0 (en) | Treatment of bowel-dependent neurological disorders | |
AU6462500A (en) | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement | |
HUP0103856A3 (en) | Pharmaceutical composition for the treatment of acute disorders | |
HUP9904525A3 (en) | Pharmaceutical compositions for the treatment of neurological disorders comprising s-(-)-n-propargyl-1-amino indan | |
IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
IL141263A0 (en) | Methods for treatment of neurological disorders | |
HK1044944A1 (en) | 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders | |
AU6910600A (en) | Methods for the treatment of mental disorders | |
AU3977700A (en) | Method of treating neurological disorders | |
AU1578295A (en) | Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders | |
GB9926968D0 (en) | Treatment of neurological disorders | |
AU5912900A (en) | Quinuclidine derivatives for treatment of neurological disorders | |
HUP0301553A3 (en) | Pharmaceutical compositions and their use for treating neurological disorders | |
AU2003278084A1 (en) | Benzo(d)azepine derivatives for the treatment of neurological and psychiatric disorders | |
AU5414100A (en) | Chroman derivatives against neurological disorders | |
SI1148873T1 (en) | Highly purified ethyl epa and other epa derivatives for neurological disorders | |
EP1053748A4 (en) | Remedies for neurological disorders | |
HU0700811D0 (en) | Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders | |
IL136949A0 (en) | 1,4-diazacycloheptane derivatives for the treatment of neurological disorders | |
AU5689300A (en) | Thiochroman derivatives against neurological disorders | |
AU7521598A (en) | Aralkoxy-morphinan derivatives for treatment of cns disorders |